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Abstract
Background
This study aimed to evaluate the relationship between cigarette smoking and coronary ath-
erosclerotic burden, volume and composition as determined in-vivo by grayscale and virtual
histology (VH) intravascular ultrasound (IVUS).
Methods and Results
Between 2008 and 2011, (VH-)IVUS of a non-culprit coronary artery was performed in 581
patients undergoing coronary angiography. To account for differences in baseline charac-
teristics, current smokers were matched to never smokers by age, gender and indication for
catheterization, resulting in 280 patients available for further analysis. Coronary atheroscle-
rotic plaque volume, burden, composition (fibrous, fibro-fatty, dense calcium and necrotic
core) and high-risk lesions (VH-IVUS derived thin-cap fibroatheroma (TCFA), plaque bur-
den70%, minimal luminal area4.0 mm2) were assessed. Cigarette smoking showed a
tendency towards higher coronary plaque burden (mean±SD, 38.6±12.5% in current versus
36.4±11.0% in never smokers, p = 0.080; and odds ratio (OR) of current smoking for plaque
burden above versus below the median 1.69 (1.04–2.75), p = 0.033). This effect was driven
by an association in patients presenting with an acute coronary syndrome (ACS) (current
smokers, plaque burden 38.3±12.8% versus never smokers, plaque burden 35.0±11.2%, p
= 0.049; OR 1.88 (1.02–3.44), p = 0.042). Fibrous tissue tended to be lower in current smok-
ers (mean±SD, 57.7±10.5% versus 60.4±12.6%, p = 0.050) and fibro-fatty tissue was higher
in current smokers (median[IQR], 9.6[6.0–13.7]% versus 8.6[5.8–12.2]%, p = 0.039). How-
ever, differences in percentage necrotic core and dense calcium could not be demon-
strated. Also, no differences were found with regard to high-risk lesions.
Conclusions
An association between smoking and degree of coronary atherosclerosis was present in
patients undergoing coronary angiography who presented with ACS. Although smoking
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was associated with higher fibro-fatty percentage, no associations could be demonstrated
with percentage necrotic core, nor with VH-IVUS derived TCFA lesions. Since the magni-
tude of the differences in both degree and composition of atherosclerosis was modest, clini-
cal relevance of the findings may be questioned.
Introduction
Cigarette smoking is a well-known risk factor for developing coronary artery disease (CAD).
Previous epidemiologic studies have demonstrated that cigarette smoking is associated with
severity of atherosclerosis on both coronary angiography and coronary CT angiography [1,2],
increased risk of myocardial infarction [3] and cardiovascular death [4,5].
In line with the above, several pathophysiologic effects of cigarette smoke exposure on car-
diovascular function have been described. Both active and passive cigarette smoke exposure
have been shown to promote endothelial dysfunction, stimulate inflammatory processes at the
vessel wall and enhance vascular prothrombotic effects [6,7]. Thus, ample fundamental
research evidence is available demonstrating that smoking directly impacts multiple aspects of
atherosclerosis. However, less is currently known about the associations of smoking with in-
vivo, macroscopic plaque composition and plaque vulnerability. Although coronary angiogra-
phy enables evaluation of the unobstructed part of the lumen, it does not provide information
on the structure of the arterial wall itself. Grayscale intravascular ultrasound (IVUS) also pro-
vides limited information on plaque characteristics.
Virtual histology (VH)-IVUS of the coronary arteries allows spectral analysis of backscat-
tered radiofrequency ultrasound signal and herewith enables in-vivo analysis of the composi-
tion of atherosclerotic plaque as well as identification of thin-cap fibroatheroma (TCFA)
lesions [8]. Until now, the association between smoking and in-vivo coronary plaque composi-
tion has only been examined in two studies. The first [9,10] applied VH-IVUS and examined
several plaque components, but did not assess VH-IVUS derived TCFA. The second [11] used
integrated backscatter IVUS, which is based on the same principle as VH-IVUS, but examined
30 patients only.
The main objective of the current study is to evaluate the relationship between cigarette
smoking and coronary atherosclerotic plaque burden, volume and composition as assessed by
(VH-)IVUS, including VH-IVUS derived TCFA lesions, in patients undergoing coronary cath-
eterization for stable coronary artery disease (CAD) or acute coronary syndrome (ACS). With
this investigation we aim to improve our understanding of the complex pathophysiologic rela-
tion between cigarette smoke exposure and cardiovascular disease.
Methods
Study population and baseline characteristics
This study was performed within the framework of the European collaborative Project on
Inflammation and Vascular Wall Remodeling in Atherosclerosis—Intravascular Ultrasound
(ATHEROREMO-IVUS) study. The design of the ATHEROREMO-IVUS study has been
described in detail elsewhere [12]. In brief, 581 patients who underwent diagnostic coronary
angiography or percutaneous coronary intervention (PCI) for ACS or stable CAD have been
included in this study between 2008 and 2011 at Erasmus MC, Rotterdam, the Netherlands.
The ATHEROREMO-IVUS study has been approved by the human research ethics committee
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of the Erasmus MC. Written informed consent was obtained from all participants. The study is
registered in ClinicalTrials.gov, number NCT01789411.
Baseline characteristics of the patients, including smoking status, were prospectively entered
into a dedicated database. Smoking status was determined by self-report. Patients were catego-
rized into those who currently smoke cigarettes (including those that had quit less than 1 year
ago), those who had never smoked, and those who had smoked in the past (and had quit more
than 1 year ago). For the current sub-study, patients from the full ATHEROREMO-IVUS
study cohort were eligible when they were current or never smokers. Patients who had quit
smoking more than 1 year ago (n = 104), or for whom information on smoking was lacking
(n = 1), were excluded, leaving 476 patients eligible for analysis.
Intravascular ultrasound
Following the standard coronary angiography or PCI procedure, IVUS imaging of a non-cul-
prit coronary artery was performed. The predefined order of preference for selection of the
non-culprit vessel was: 1. left anterior descending (LAD) artery; 2. right coronary artery
(RCA); 3. left circumflex (LCX) artery. All IVUS data were acquired with the Volcano™ s5/s5i
Imaging System (Volcano Corp., San Diego, CA, USA), using a Volcano™ Eagle Eye™ Gold
IVUS catheter (20 MHz). An automatic pullback system was used with a standard pull back
speed of 0.5 mm per second. IVUS images were analyzed offline by an independent core labo-
ratory (Cardialysis BV, Rotterdam, the Netherlands) that had no knowledge of clinical data.
IVUS grayscale and virtual histology analyses were performed using pcVH 2.1 and qVH (Vol-
cano Corp., San Diego, CA, USA) software.
The external elastic membrane and luminal borders were contoured for each frame (median
interslice distance, 0.40 mm). Degree and phenotype of the atherosclerotic plaque were
assessed. Plaque volume was defined as the percent of the volume of the external elastic mem-
brane occupied by atheroma, i.e. percent atheroma volume. Plaque burden was defined as pla-
que and media cross-sectional area divided by external elastic membrane cross-sectional area.
A coronary lesion was defined as a segment with a plaque burden of more than 40% in at least
3 consecutive frames. Using VH-IVUS, the composition of the atherosclerotic plaques was
characterized into 4 different tissue types: fibrous (FI), fibro-fatty (FF), dense calcium (DC)
and necrotic core (NC) [13]. These tissue type components were expressed as percentages of
total plaque volume. Three types of high-risk lesions were identified: 1. VH-IVUS derived
thin-cap fibroatheroma (TCFA) lesion, defined as a lesion with presence of>10% confluent
necrotic core in direct contact with the lumen; 2. Lesion with large plaque burden, defined as a
lesion with a plaque burden of70%; 3. Stenotic lesion, defined as a lesion with a minimal
luminal area of4.0 mm2 [13,14]. In addition, remodeling index was calculated and expressed
as the external elastic membrane cross-sectional area at the site of minimal luminal area
divided by the reference external elastic membrane cross-sectional area. The reference site was
selected<10 mm proximal to the lesion. Positive remodeling (arterial expansion) was defined
as a remodeling index of>1.05, and negative remodeling (arterial shrinkage) was defined as a
remodeling index of<0.95.
Statistical analysis
Categorical data are presented as numbers and percentages. Normality of the distributions of
continuous variables was examined by visual inspection of the histogram and by normal Q-Q
plots. Continuous data are presented as mean±standard deviation (SD) or as median and inter-
quartile range (IQR), depending on their distribution. Plaque volume, percentage fibro-fatty
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volume (% FF) and percentage dense calcium volume (% DC) appeared to be non-normally
distributed and were therefore ln-transformed for further analyses.
Baseline clinical and procedural characteristics of current smokers and those who had never
smoked were compared using the independent Student’s t-test for continuous variables and
using the χ² test for categorical variables. Subsequently, to account for differences in baseline
characteristics between current smokers and those who had never smoked, we performed a
matching procedure. Every current smoker was matched to a never smoker by age (±5 years),
gender and indication for catheterization (acute coronary syndrome or stable angina pectoris).
In the matched set, baseline clinical, procedural and (VH-)IVUS characteristics of current
smokers and never smokers were compared using the paired samples t-test for continuous vari-
ables and the McNemar test or marginal homogeneity test for categorical variables, whichever
was appropriate.
Subsequently, we performed conditional logistic regression to examine the associations
between smoking status and high plaque burden (above versus below the median), as well as
smoking status and the three types of high-risk lesions (VH-IVUS derived TCFA, lesion with
plaque burden70%, lesion with minimal luminal area4.0 mm2).
Finally, to examine effect modification by age and indication for catheterization, we strati-
fied on these variables and repeated all the above described analyses in subgroups. For this pur-
pose, we divided age into tertiles (based on age of the smokers).
All data were analyzed with SPSS software (SPSS 20.0, IBM corp., Armonk, NY, USA). All
statistical tests were two-tailed and p-values<0.050 were considered statistically significant.
Results
Baseline characteristics
Baseline clinical and procedural characteristics of the total patient population are presented in
Table 1. Current (n = 169) and never smokers (n = 307) differed significantly at baseline. Cur-
rent smokers, on average, were significantly younger (55.7±10.8 years vs. 64.4±10.8, p<0.001)
than the never smokers. Significantly more men were present among the current smokers
(79.3% vs. 70.7%, p = 0.041), and current smokers were less likely to have predisposing risk fac-
tors such as hypertension (p<0.001), dyslipidemia (p = 0.030) and diabetes mellitus
(p = 0.038). Furthermore, the indication for coronary angiography or PCI also differed signifi-
cantly between the two groups. Current smokers more often underwent catheterization for
ACS and less often for stable CAD compared to the never smokers (p<0.001).
After the matching procedure, baseline clinical and procedural characteristics were similarly
distributed between the two groups (Table 2).
Degree of coronary atherosclerosis
To assess differences in degree of atherosclerosis between current smokers and never smokers,
plaque volume and plaque burden were examined in the coronary segments. Plaque volume
(median (IQR)) was similar for current and never smokers (221.8[134.6–312.5]mm3 versus
207.5[134.5–293.2]mm3) (Table 3). On the other hand, with regard to plaque burden, there
was a tendency towards higher values in current smokers (Table 3). Plaque burden (mean±SD)
was 38.6±12.5% in current smokers versus 36.4±11.0% in never smokers, p = 0.080 (Fig 1).
The odds ratio (OR) (95% confidence interval (CI)) of current smoking for plaque burden
above the median versus below the median was 1.69 (1.04–2.75), p = 0.033 (Table 4). After
stratification on age, this tendency towards higher plaque burden in current smokers was only
present in the lower age tertile (37.8±12.6% versus 33.9±11.1%, p = 0.09). However, the OR for
plaque burden above the median versus below the median was not significant in this subgroup
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(S1 and S2 Tables). Furthermore, after stratification on indication for catheterization, plaque
burden was significantly higher in current smokers presenting with ACS (38.3±12.8% versus
35.0±11.2%, p = 0.049 and OR 1.88 (1.02–3.44), p = 0.042) (S3 and S4 Tables).
The number of patients with1 lesions was similar in current and never smokers (85.7%
vs. 87.9%, p = 0.72) (Table 3). The odds ratio of having one or more lesions with plaque burden
70% was also similar (OR (95% CI): 1.47 (0.76–2.83)), as was the odds ratio of having one or
more lesions with a minimal luminal area of4.0 mm2 (Table 4). Subgroup analysis did not
provide additional insights.
As described above, we found a borderline association with plaque burden, but no associa-
tion with plaque volume. This seeming discrepancy may be due to the fact that plaque burden
is not a direct measure of three dimensional plaque volume, but rather a two dimensional mea-
sure that also accounts for arterial wall remodeling. Specifically, the discrepancy may be
explained by an association with negative remodeling. Therefore, we examined associations of
smoking with remodeling in a post-hoc analysis. Smoking displayed a tendency toward a posi-
tive association with negative remodeling (OR (95% CI): 1.58 (0.89–2.81), p = 0.12), as well as
a tendency toward a negative association with positive remodeling (OR (95% CI): 0.47 (0.21–
1.05), p = 0.065).
Table 1. Baseline clinical and procedural characteristics, before matching.
Current smokers Never smokers P-value
(n = 169) (n = 307)
Patient characteristics
Age, years 55.7 ± 10.8 64.4 ± 10.8 <0.001
Male gender, n (%) 134 (79.3) 217 (70.7) 0.041
Hypertension, n (%) 63 (37.5) 171 (55.7) <0.001
Dyslipidemia, n (%) 80 (47.6) 178 (58.0) 0.030
Diabetes mellitus, n (%) 20 (11.8) 59 (19.2) 0.038
Positive family history, n (%) 86 (51.2) 158 (51.5) 0.95
Peripheral artery disease, n (%) 12 (7.1) 15 (4.9) 0.32
Previous MI, n (%) 38 (22.5) 103 (33.6) 0.011
Previous PCI, n (%) 37 (21.9) 103 (33.6) 0.008
Previous CABG, n (%) 1 (0.6) 12 (3.9) 0.034
Previous stroke, n (%) 4 (2.4) 16 (5.2) 0.14
History of renal insufﬁciency, n (%) 8 (4.7) 17 (5.5) 0.71
Procedural characteristics
Indication for catheterization <0.001
Acute coronary syndrome, n (%) 119 (72.1) 151 (49.5)
Stable angina pectoris, n (%) 46 (27.9) 154 (50.5)
Coronary artery disease 0.24
No signiﬁcant stenosis, n (%) 9 (5.3) 27 (8.8)
1-vessel disease, n (%) 90 (53.3) 151 (49.2)
2-vessel disease, n (%) 56 (33.1) 91 (29.6)
3-vessel disease, n (%) 14 (8.3) 38 (12.4)
Vessel imaged by VH-IVUS 0.15
LAD 71 (42.0) 101 (33.1)
RCA 44 (26.0) 95 (31.1)
LCX 54 (32.0) 109 (35.7)
Values are mean ± SD or n (%). P-values were obtained by independent samples t-test or Chi-squared test, whichever was appropriate.
doi:10.1371/journal.pone.0141093.t001
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Composition of coronary atherosclerosis
VH-IVUS segment and lesion characteristics of the matched smokers and never smokers are
listed in Table 3. Percentage of fibrous tissue (% FI) volume in the examined coronary segment
tended to be lower in current smokers (57.7±10.5% vs. 60.4±12.6%, p = 0.050), which was
driven by the lower age tertile (56.5±10.4% vs. 61.4±12.8%, p = 0.042) (S1 Table). Percentage of
fibro-fatty tissue volume was higher in current smokers (9.6[6.0–13.7]% vs. 8.6[5.8–12.2]%,
p = 0.039) (Table 3 and Fig 2), which was driven by the upper age tertile (11.1[6.3–15.3]% vs.
8.3[5.8–12.3], p = 0.08) (S1 Table). However, differences in percentage necrotic core (% NC)
volume and dense calcium volume could not be demonstrated, and prevalence of1 TCFA
lesions was the same in current and never smokers (both 40.7%, Tables 3 and 4). After stratifi-
cation on age, TCFA lesions tended to occur less often in current smokers in the upper age ter-
tile (23.4% vs 44.7%, p = 0.06; OR 0.41 (0.17–0.99, p = 0.048) (S1 and S2 Tables).
Table 2. Baseline clinical and procedural characteristics, after matching.
Current smokers Never smokers P-value
(n = 140) (n = 140)
Patient characteristics
Age, years 57.9 ± 9.7 58.1 ± 9.5 MV
Male gender, n (%) 108 (77.1) 108 (77.1) MV
Hypertension, n (%) 58 (41.4) 73 (52.1) 0.10
Dyslipidemia, n (%) 74 (52.9) 74 (52.9) 1.00
Diabetes mellitus, n (%) 19 (13.6) 28 (20.0) 0.21
Positive family history, n (%) 68 (48.9) 75 (53.6) 0.53
Peripheral artery disease, n (%) 12 (8.6) 7 (5.0) 0.36
Previous MI, n (%) 33 (23.6) 35 (25.0) 0.89
Previous PCI, n (%) 33 (23.6) 45 (32.1) 0.11
Previous CABG, n (%) 0 (0.0) 3 (2.1) 0.25
Previous stroke, n (%) 4 (2.9) 7 (5.0) 0.51
History of renal insufﬁciency, n (%) 6 (4.3) 11 (7.9) 0.33
Procedural characteristics
Indication for catheterization MV
Acute coronary syndrome, n (%) 96 (68.6) 96 (68.6)
Stable angina pectoris, n (%) 44 (31.4) 44 (31.4)
Coronary artery disease 0.33
No signiﬁcant stenosis, n (%) 6 (4.3) 14 (10.0)
1-vessel disease, n (%) 74 (52.9) 76 (54.3)
2-vessel disease, n (%) 47 (33.6) 36 (25.7)
3-vessel disease, n (%) 13 (9.3) 14 (10.0)
Vessel imaged by VH-IVUS 0.51
LAD 56 (40.0) 50 (35.7)
RCA 40 (28.6) 43 (30.7)
LCX 44 (31.4) 47 (33.6)
MV, matching variable. Values are mean ± SD or n (%).
P-values were obtained by paired samples t-test, McNemar test or Marginal Homogeneity, whichever was appropriate.
doi:10.1371/journal.pone.0141093.t002
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Discussion
This study investigated the associations of cigarette smoking with coronary atherosclerotic pla-
que burden, volume and composition as determined by (VH-)IVUS of a non-culprit section of
a coronary artery in patients undergoing coronary angiography. Cigarette smoking showed a
tendency towards higher coronary plaque burden, which was driven by an association in the
subgroup of patients presenting with ACS. The magnitude of this effect was very modest. Fur-
thermore, while smoking was associated with higher percentage of fibro-fatty plaque volume,
no associations could be demonstrated with percentage necrotic core volume, nor with VH-I-
VUS derived TCFA lesions, suggesting that smoking has no major influence on plaque
vulnerability.
Although several studies have examined the association between smoking and degree of cor-
onary atherosclerosis as measured by IVUS [9–11,15–17], so far only one large study has
applied virtual histology (VH-IVUS) to assess its association with composition of coronary
atherosclerosis and plaque vulnerability. Philipp et al [10] found that smoking was not associ-
ated with plaque composition in a sample of 990 consecutive, non-selected patients, which is in
line with our findings. However, they did not perform a lesion-based analysis, or a categoriza-
tion into high-risk lesions such as TCFA, as we did. Missel et al [9] examined a subset of 473
male patients with de novo culprit coronary lesions from the same registry, and found a higher
NC/DC ratio, a measure of plaque vulnerability, in smokers. Other VH parameters were not
significantly influenced by smoking. A post-hoc analysis in our dataset showed no relation
Table 3. (VH-)IVUS segment and lesion characteristics, after matching.
Current smokers Never smokers P-value
(n = 140) (n = 140)
(VH-)IVUS segment parameters
Segment length, mm 45.4 ± 15.4 44.7 ± 13.2 0.67
Degree of atherosclerosis
Plaque volume, mm3 221.8 [134.6–312.5] 207.5 [134.5–293.2] 0.60
Plaque burden, % 38.6 ± 12.5 36.4 ± 11.0 0.080
Composition of atherosclerosis
% FI volume 57.7 ± 10.5 60.4 ± 12.6 0.050
% FF volume 9.6 [6.0–13.7] 8.6 [5.8–12.2] 0.039
% NC volume 21.6 ± 8.0 20.8 ± 8.8 0.37
% DC volume 7.6 [4.7–13.9] 8.0 [4.3–13.3] 0.62
(VH-)IVUS lesion parameters
1 Lesions, n (%) 120 (85.7) 123 (87.9) 0.73
Presence of high risk lesions, n (%) 90 (64.3) 83 (59.3) 0.46
High risk lesion type:
Degree of atherosclerosis
1 Lesion with plaque burden 70%, n (%) 31 (22.1) 27 (19.3) 0.65
1 Lesion with MLA 4.0mm2, n (%) 43 (30.7) 42 (30.0) 1.00
Composition of atherosclerosis
1 TCFA, n (%) 57 (40.7) 57 (40.7) 1.00
FI, ﬁbrous; FF, ﬁbro-fatty; NC, necrotic core; DC, dense calcium; MLA, minimal lumen area; TCFA, thin-cap ﬁbroatheroma.
Values are mean ± SD, median [interquartile range], or n (%).
P-values were obtained by paired samples t-test or McNemar test, whichever was appropriate.
doi:10.1371/journal.pone.0141093.t003
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between smoking and NC/DC ratio (results not shown). In a small, underpowered study of 30
patients with stable angina Sano et al [11] found no association of plaque characteristics with
smoking either. Remarkably, in our subgroup analysis, we found that TCFA lesions tended to
occur less often in current smokers in the upper age tertile. A healthy survivor effect may pose
a potential explanation for this finding.
With regard to degree of coronary atherosclerosis as assessed by IVUS, previous studies
have rendered contradicting results. Nicholls et al [16] demonstrated that smoking was a weak
independent predictor of percent plaque volume in 654 patients with a clinical indication for
diagnostic coronary angiography. Furthermore, Von Birgelen et al [17] found an association
between smoking and progression of plaque plus media cross-sectional area in 56 patients with
Fig 1. Difference in plaque burden between current and never smokers.
doi:10.1371/journal.pone.0141093.g001
Table 4. Odds ratios of current smoking for high plaque burden and for presence of high risk lesion
types.
OR (95% CI) P-value
(VH-)IVUS segment parameters
Plaque burden
Below the median 1.00 (reference)
Above the median 1.69 (1.04–2.75) 0.033
(VH-)IVUS lesion parameters
1 Lesion with plaque burden 70% 1.20 (0.66–2.17) 0.55
1 Lesion with MLA 4.0mm2 1.03 (0.63–1.71) 0.90
1 TCFA 1.00 (0.63–1.60) 1.00
OR, odds ratio; CI, conﬁdence interval; MLA, minimal lumen area; TCFA, thin-cap ﬁbroatheroma.
P-values were obtained by conditional logistic regression.
doi:10.1371/journal.pone.0141093.t004
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de novo, hemodynamically nonsignificant plaques. In contrast, Kahlon et al concluded that
smoking was not correlated with plaque burden in 897 consecutive patients undergoing IVUS
investigation [15]. In our total study population, the association between smoking and plaque
burden as well as plaque volume was not substantial. However, we did find such an association
in the subgroup of patients presenting with ACS. In this subgroup, current smokers showed a
higher plaque burden than never smokers. These findings concur with the fact that smoking is
associated with both greater degrees of stenosis and an increased likelihood of acute plaque
events [18], as well as with the fact that smoking is associated with reduced fibrinolytic poten-
tial and thus a pro-thrombotic phenotype [18]. Nevertheless, it should be recognized that the
magnitude of the difference in degree of atherosclerosis between current and never smokers
presenting with ACS was modest in our study, and that both pathophysiologic and clinical rele-
vance of the findings may be questioned. Previous studies on smoking and degree of athero-
sclerosis on IVUS have not stratified their results on indication for angiography.
Our results do not support the hypothesis that smoking is associated with coronary plaque
vulnerability. This may be explained by the possibility that plaque erosion, and not as much
vulnerable plaque rupture, is the intermediate between smoking and cardiac adverse events.
Histopathological studies have shown that luminal thrombosis may result from two different
pathologies, namely plaque rupture and plaque erosion [19–22]. Plaque rupture seems to be
highly associated with TCFAs and causes thrombotic coronary occlusion. Plaque erosion is
characterized by an acute thrombus in direct contact with the intimal plaque, rich in smooth
muscle cells with surrounding proteoglycan matrix and minimal inflammation. The lesions
tend to be eccentric, infrequently calcified and cause less severe narrowing at sites of thrombo-
sis [20,21]. Most eroded lesions have an absent or poorly defined necrotic core, which, when
present, is not in close proximity to the luminal thrombus. Studies have shown that smoking is
associated with plaque erosion and frequently causes coronary thrombosis [20,21]. This may
possibly explain the general absence of an association of smoking with coronary plaque compo-
sition as assessed by VH-IVUS in the literature, and the inconsistent findings with regard to
Fig 2. Difference in composition of coronary atherosclerosis between current and never smokers, after matching. FI = fibrous. FF = fibro-fatty.
DC = dense calcium. NC = necrotic core.
doi:10.1371/journal.pone.0141093.g002
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smoking and degree of coronary atherosclerosis as assessed by grayscale IVUS. We found that
current smokers tend to have a slightly lower percentage fibrous plaque volume (driven by the
lower age tertile), and that they have a somewhat higher percentage fibro-fatty plaque volume;
however, this trend did not persist with regard to percentage necrotic core or presence of
TCFA. These findings do not preclude plaque erosion as the underlying mechanism. Moreover,
histopathological studies examining coronary arteries suggest that smoking predisposes
patients to coronary thrombosis rather than promoting the progression of atherosclerosis
[21,23,24]. These findings are supported by clinical patient studies showing that smokers seem
to have a more favourable response to fibrinolytic therapy compared to nonsmokers, which
may be attributed to their hypercoagulable state [25–27]. In the present study, we did not focus
on the influence of smoking on blood coagulation.
Smoking displayed a tendency toward a positive association with negative remodeling, as
well as a tendency toward a negative association with positive remodeling. A possible explana-
tion for these seemingly counterintuitive findings lies in the interpretation of the early phases
of remodeling. Modest positive lesion remodeling may be considered as a physiological, and
thus favourable, response to progression of atherosclerotic plaque (also known as the Glagov
adaptive phenomenon) [28]. In this light, smoking may point towards a lower adaptive capac-
ity to atherosclerotic burden.
Some aspects of this study warrant consideration. A single non-culprit coronary vessel was
imaged. This study design of ATHEROREMO-IVUS was based on the hypothesis that such a
non-stenotic segment adequately reflects the state of the coronary wall of the larger coronary
tree [12]. Both ex vivo and in vivo studies using IVUS in patients presenting with myocardial
infarction have demonstrated the existence of additional TCFAs other than the culprit lesion
in the culprit artery, as well as TCFAs in other arteries than the culprit artery [29]. Accordingly,
the results of ATHEROREMO-IVUS, which we published earlier, have confirmed that the
characteristics of the coronary wall of this non-culprit coronary vessel are strongly associated
with subsequent cardiovascular outcome [30]. In addition, previous studies evaluating IVUS
have similarly demonstrated that the coronary wall of comparable non-culprit, non-stenotic
segments of a single vessel does reflect larger coronary disease burden and is associated with
subsequent events [31,32]. Nevertheless, simultaneous assessment of the culprit vessel might
have provided additional insights into the underlying disease mechanisms. Another limitation
of this study is that IVUS is formally not capable of detecting the TCFA according to histopath-
ological definitions [33,34]. Nonetheless, a concept of VH-IVUS derived TCFA has been postu-
lated for plaques with a plaque burden 40% and a confluent necrotic core 10% in direct
contact with the lumen in at least three VH-IVUS frames [14,33], and we have demonstrated
earlier that such VH-IVUS derived TCFA lesions strongly and independently predict the
occurrence of major adverse cardiac events within the current study population [30]. Further-
more, smoking status was determined by self-report in this cross-sectional study. To minimize
the risk of misclassification, we excluded former smokers from our study. Finally, a matching
procedure was necessary because of differences in baseline characteristics between smokers
and never smokers. Since part of the smokers (n = 29) could not be matched to a never smoker,
this study design entailed some loss of statistical power. Moreover, statistical power for the
stratified analyses was limited.
In conclusion, we were not able to demonstrate a clear and strong association of cigarette
smoking with degree of atherosclerosis and coronary plaque vulnerability as assessed by VH-I-
VUS in the current study. Additional studies, using various intravascular imaging modalities,
are needed to further describe the association between smoking and in-vivo degree and compo-
sition of coronary plaque, and to herewith discern the mechanisms underlying the association
between smoking and cardiac adverse events.
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